Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,114.00
Bid: 1,115.00
Ask: 1,117.00
Change: -26.00 (-2.28%)
Spread: 2.00 (0.179%)
Open: 1,118.00
High: 1,140.00
Low: 1,114.00
Prev. Close: 1,140.00
HSX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

1 Dec 2010 16:38

RNS Number : 2143X
Hiscox Ltd
01 December 2010
 



HISCOX Ltd

Change of Board of Directors

 

 

Hamilton, Bermuda (1 December 2010) -- Hiscox Ltd (LSE:HSX), the international specialist insurer, today announces the following changes to the Board of Hiscox Ltd.

 

Richard Gillingwater and Robert (Bob) McMillan have been appointed as non-executive directors with effect from 1 December 2010.

 

Richard Gillingwater, 54, CBE, is Dean of Cass Business School. Educated at Oxford and a lawyer by training, he spent a decade at Kleinwort Benson, before moving to and eventually becoming joint head of corporate finance for BZW, a division of Barclays Bank. When that became Credit Suisse First Boston, he became chairman of European Investment Banking.

 

In 2003 he became chief executive and later chairman of the Shareholder Executive which manages the Government's day-to-day relationships with government-owned businesses. He is currently a non-executive director of Scottish and Southern Energy. He is also chairman of CDC, the development finance body. He was a non-executive director of Tomkins until September 2010, Debenhams until April 2009 and Qinetiq Group until January 2006. He was awarded a CBE in the Queen's Birthday Honours List 2008 in recognition of his services to the financial services industry.

 

Robert Hiscox, Chairman said "We are delighted to welcome such a distinguished and experienced director to the Board."

 

Robert (Bob) McMillan, 58, a US citizen, spent 24 years with the Progressive Insurance Corporation where he served in various positions including national director of product development, then claims before becoming national director of marketing. He led Progressive's initiatives in multi-channel distribution, financial responsibility based rating, and immediate response claims. He has received two United States patents related to motor insurance pricing. He has lectured on business innovation at the University of Virginia's Darden School of Business and at the Harvard Business School. He has been a non-executive director of Hiscox Inc. since March 2007.

 

Robert Hiscox, Chairman said "Bob has been a valued member of the Hiscox Inc. board and we are pleased that he has agreed to join the Hiscox Ltd board."

 

There are no other details that are required to be disclosed in respect of the appointments of Richard Gillingwater and Robert McMillan under Paragraph 9.6.13 of the Listing Rules of the UK Listing Authority.

 

For further information:

 

Hiscox Ltd

Charles Dupplin, Company Secretary, Bermuda +1 441 278 8300

Kylie O'Connor, Head of Communications, London +44 (0) 207 448 6656

 

Maitland +44 (0) 207 379 5151

Anthony Silverman

Rebecca Mitchell

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGGMWPUPUGQG
Date   Source Headline
13th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSApplication to be Admitted to Official List
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20244:17 pmRNSTotal Voting Rights
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
30th May 202412:40 pmRNSAnnouncement of Scrip Reference Share Price
30th May 202412:14 pmRNSAnnouncement of Scrip Reference Share Price
30th May 20247:00 amRNSTransaction in Own Shares
29th May 20247:00 amRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSTransaction in Own Shares
22nd May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSTransaction in Own Shares
20th May 20247:00 amRNSTransaction in Own Shares
17th May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares
15th May 20247:00 amRNSTransaction in Own Shares
14th May 20247:00 amRNSTransaction in Own Shares
13th May 20247:00 amRNSTransaction in Own Shares
10th May 20247:00 amRNSResult of AGM
10th May 20247:00 amRNSTransaction in Own Shares
9th May 20241:11 pmRNSSyndicates 33 and 6104 - results and estimates
9th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:01 amRNSShare Repurchase Programme.
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSQ1 2024 Trading Statement
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20243:57 pmRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.